NANOBIOTIX and LianBio Announce First Patient Enrolled in As

Regional activation for Nanobiotix pivotal Phase 3 trial in head and neck cancer proceeds as planned with first patient enrolled in Asia by partner LianBio The collaboration continues to build

Related Keywords

China , Thailand , South Korea , Singapore , Ligia Vela Reid , Brandon Owens , Kate Mcneil , Katherine Smith , Pierre Louis Germain , Yizhe Wang , Elizabeth Anderson , Communications Investor Relations , Linkedin , French Financial Markets Authority Autorit , Lianbio Communications , Twitter , Nanobiotix Communications , Drug Administration , Nasdaq , Exchange Commission , Euronext , Nanobiotix Phase , Chief Executive Officer , Greater China , Choice Phase , Nanobiotix Study , Fast Track , Private Securities Litigation Reform Act , Annual Report , French Financial Markets Authority , Investor Relations , Louis Germain , Bio Communications , Nanobiotix , Lianbio , Nnounce , First , Patient , Unrolled , Sia , Hase , Anoray , Trial , Valuating , Nbtxr3 , Treatment , Head , Neck , Dancer ,